Avoidance of high concentration oxygen in chronic obstructive pulmonary disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. ERS International Congress, Madrid, 2019: highlights from the Respiratory Intensive Care Assembly.ERJ open research · 2020
   Article
2. European Respiratory Society International Congress 2018: highlights from Assembly 2 on respiratory intensive care.ERJ open research · 2019
   Review
3. A study of attitudes, beliefs and organisational barriers related to safe emergency oxygen therapy for patients with COPD (chronic obstructive pulmonary disease) in clinical practice and research.BMJ open respiratory research · 2016
   Article
4. Supplementary oxygen for nonhypoxemic patients: O2 much of a good thing?Critical care (London, England) · 2011
   Review

Corrections and comments

• Comment on
  Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial.2010

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as